Superbug crisis has rocked this world with million deaths due to failure of potent antibiotics. Thousands mdr genes with hundreds of mutant isomers are generated. Small integrons and R-plasmids have combined with F'-plasmids creating a space for >10-20 of mdr genes that inactivate antibiotics in different mechanisms. Mdr genes are created to save bacteria from antibiotics because gut microbiota synthesize >20 vitamins and complex bio-molecules needed for >30000 biochemical reactions of human metabolosome. In other words, mdr gene creation is protected from both sides, intestinal luminal cells and gut bacteria in a tight symbiotic signalling system. We have proposed, to avert the crisis all vitamin metabolizing genes will be acquired in MDRplasmids if we continue oral antibiotics therapy. Therefore, we have checked the plasmid databases and have detected thiamine, riboflavin, folate, cobalamine and biotin metabolizing enzymes in MDR plasmids. Thus vit genes may mobilise recently into MDR-plasmids and are likely essential for gut microbiota protection. Analysis found that cob and thi genes are abundant and likely very essential than other vit genes.
Introduction

MDR bacteria contaminated in air dust and rain water
Life creation is due to chemical evolution and Darwin's adaptation theory tells the unique way of changes in cellular structure and metabolism in different eco-system. Microscopic unicellular bacteria, fungi, yeast, protozoa, and algae are regulating water and atmosphere circling plant and animal kingdoms (Pathak et al., 1993; Ahmadjian, 2000) . A battle among the creatures is maximum at all points where simple bacteria create crisis in the human life creating toxins and other metabolic effects (Grossart et al., 2013; Mckenna, 2013) . Microbes are in symbiotic relation with human and 2x10 12 gut bacteria perform various syntheses of bio-molecules like vitamins, butyrate, unsaturated fatty acids, bile salt and prostaglandin (Le Chatelier et al., 2013) . Recently, multidrug-resistant microbes have increased in global water and atmosphere (PM10 particulates increased) posing a threat to human population worldwide (Ibiene et al., 2011; Chakraborty, 2017b) . Antibiotics had cured most infections between1940-1990 although gradual increase in drug resistance was detected in many continents as early as 1960 (Reynolds , 1989; Paul et al., 2013) . Indeed the drug industry had always run to discover potent derivatives like cefotaxime, ceftrioxane, imipenem and dorripenem in place of old drug like ampicillin and oxacillin (Laxminarayan et al., 2013) .
Most harmful changes have happened when 2-15 kb R-plasmids and integrons are combined with 62kb F'-plasmids and such MDR conjugative plasmids donate mdr genes into all bacteria more easily by conjugation (Chakraborty, 2016a) . Thus, 40% common bacteria in Ganga river water and Bay of Bengal sea water are ampicillin resistant and most bacteria (>95%) have isolated from human and animal are ampicillin and tetracycline resistant being two early mdr genes (amp and tet that have sequenced in 1965 as plasmid pBR322) and many mdr genes are detected in plasmids of intestinal bacteria (Morten et al., 2009) .
Beta-lactamase genes are strongly diversified
Most notorious MDR gene is β-lactamase gene (accession nos. J01749, X92506, AF227505, AF124204) which hydrolyses lactam ring CO-N bond of penicillins and has diversified into 20 different classes (250-382aa) like blaTEM, blaOXA, blaCTX-M, blaCMY, blaKPC and blaNDM-1etc (Bush & Jacoby, 2010; Chakraborty, 2016b; Stiffler et al., 2015) . Class B enzymes are Zn++-dependent β-lactamases that demonstrate a hydrolytic mechanism different from that of the serine β-lactamases of classes A, C, and D. Organisms producing these enzymes usually exhibit resistance to penicillins, cephalosporins, carbapenems, and the clinically available β-lactamase inhibitors. Class C AmpC β-lactamases include CMY-2, P99, ACT-1, and DHA-1, which are usually encoded by bla genes located on the bacterial chromosome, although plasmid-borne AmpC enzymes are becoming more prevalent.
Moreover, OXA-2, OXA-23, OXA-48 and OXA-51/58 have no sequence similarity but all hydrolyses carbapenems and some inhibitors. The Klebsiella pneumoniae New Delhi metallo-β-lactamase-1 (NDM-1) was discovered in 2009 in an Indian patient that could hydrolyse all β-lactums (Mataseje et al., 2016) . However, NDM1 outbreaks in England and USA as early as 2010 and were found in plasmid as well as chromosome of K. pneumoniae, E. coli and Acinetobacter baumannii as well as to lesser extent in Providentia sp. and
Enterobacter sp. (Chakraborty, 2016a) .
Other major mdr genes that inactivate antibiotics
StrA/B gene (accession nos. KT225462, LN555650) encodes an enzyme (~267aa) that acetylates streptomycin and diversified aac (accession nos. AB061794, JN596279) and aph (accession nos. X01702, U32991) mdr genes acetylate and phosphorylate aminoglycoside antibiotics respectively which then could not able to bind ribosome to kill bacteria (Shaw et al., 1993; Villa et al., 2015) . (Robicsek et al., 2006; Schwarz et al., 2004) . Sul1/2 genes (accession nos. KM877269, AP012056) have been implicated in sulfamethoxazole resistance (Dallas et al., 1992) and arr3 gene (accession no. KX029331; protein id. APD70456) ribosylates refamycins which then could not inhibit bacterial RNA polymerase (Chakraborty, 2016a) .
Drug efflux genes are accumulating in large plasmids
Major drug efflux MDR genes include tet gene isomers which encode a membrane-bound drug efflux protein (~400aa) which kicks out tetracycline from bacterial cell cytoplasm and also has been diversified into tetA/B/C (accession nos. X75761, KC590080) (McMurry et al., 1980) . Other potential genes are MFS, RND and MATE types drug efflux genes that could kick out drugs in a proton-pump mechanism (Sun et al., 2014) . The MexAB-OprM system in Pseudomonas aeruginosa has the broadest substrate specificity and contributes to resistance to macrolides, aminoglycosides, sulfonamides, fluoroquinolones, tetracyclines and many β-lactams. The loss of the outer membrane protein (porin) OprD, is associated with imipenem resistance and reduced susceptibility to meropenem. Similarly, tetracycline resistant protein, tetM (accession no. AY466395, protein id. AAS45561) binds tetracycline increasing drug MIC (Croft et al., 2013; Chakraborty, 2016a) .
Target mutations are prominent mechanism for multi-resistance
The majority of rifampicin-resistant clinical isolates of M. tuberculosis harbour mutations in the 507-533 coding region of rpoB gene creating an altered β-subunit of the RNA polymerase that could not able to bind refampicin and altered KatG gene (S315T mutation) and -15C/T mutation in the promoter may be important in isoniazid resistance targeting NADHdependent enoyl-acyl carrier protein (ACP)-reductase that is involved in mycolic acid synthesis. VanA gene cluster are involved in the vancomycin resistance in Enterococcus facium (Merlo et al., 2015 ; also see, plasmids pIP501 and pAM_1) and ermA/B genes are diverged 23S rRNA methyl transferases that give resistant to macrolides (Harme et al., 2015) .
This implies that bacteria do change its target genes if new mdr gene synthesis is delayed or very high dose antibiotic is used. So bacteria need multiple gateways to inactivate drug quickly to save gut bacteria (Chakraborty, 2016c) .
Variety of large plasmids in multidrug-resistant bacteria
BlaKPC gene was located in many Klebsiella pneumoniae large (108-317kb) conjugative plasmids (accession nos. NC_022078, NC_014312 and JX283456) as well as NDM1 gene was also located in conjugative plasmids (accession nos JN420336, AP012055). Other
Escherichia coli plasmid pNDM_Dok01 and K. pneumoniae plasmid pKpANDM-1 have flanked ISAba125 elements and T4SS genes (Hu et al., 2012; Feng et al., 2015; Flach et al., 2015) . Folster JP et al (2014) reported a Vibrio cholera strain 2012EL-2176 harbouring
sul1/2, dfrA1, dfrA27, tetA, mphA, mdr-genes and also resistant to ciprofloxacin due to mutation in gyrA(S83I)/parC(S85L) as also seen in plasmid pMRV150 (accession no.
EU116442) (Carattoli, 2009; Huang et al., 2013; Hermi et al., 2015) .
MDR Genes move into chromosome to increase gene dose
In skin infection, methicillin resistance gene (mecA) encoding a penicillin-binding protein and activated with mobile genetic element, the staphylococcal cassette chromosome mec (SCCmec) has been reported in Staphylococcus aureus chromosome which also is associated with bla, aac, aad and sul1/2 types MDR genes. This implies that to avert the drug crisis, mdr genes have been mobilized into chromosome to increase in copy number and in association with multiple mdr genes (Chakraborty, 2016b) .
Vitamin metabolizing genes in bacteria
Escherichia coli K-12 synthesizes thiamine monophosphate (vitamin B1) de novo from two precursors, 4-methyl-5-(beta-hydroxyethyl) thiazole monophosphate and 4-amino-5-hydroxymethyl-2-methylpyrimidine pyrophosphate. Thiamine monophosphate is then phosphorylated to make thiamine pyrophosphate coenzyme. Five tightly linked genes (thiCEFGH) are involved and the thiC gene product is required for the synthesis of the hydroxymethylpyrimidine and thiE, thiF, thiG, and thiH gene products are required for synthesis of the thiazole. Rizobium plasmids carry many thi genes with ~38-69% similarities to E. coli enzymes (Vander Horn et al., 1993; Rodionov et al., 2002) . RibB gene (protein ids.
CDQ55093; ABU50713) of Klebsiella pneumoniae has similarity to 3,4-dihydroxy-2-butanone 4-phosphate synthase and linked to ribA (protein id. ABU50715), ribH (protein id.
ABU50714), ribE (protein id. ABU50712) of Photobacterium kishitanii (accession no.
AY849504.2) and ribX is riboflavin transport system permease (protein ids. GAX64964, AUS72405) and ribY riboflavin binding protein (protein id. GBD30789) (Lopez et al., 1987; Dallas et al., 1992; Talarico et al., 1991) . The complete aerobic and anaerobic pathways for the de novo biosynthesis of B12 are known including lower ligand or 5,6-dimethylbenzimidazole (Hazra et al., 2015) .
We have extensively reviewed the beta-lactamases (Chakraborty, 2016b) and drug acetyl transferases (Chakraborty et al., 2017) in plasmids and integrons and their association in other mdr genes (Chakraborty, 2016a; Chakraborty, 2017c,f) . From GenBank data analysis, 
Materials and Methods
Water from Ganga River was collected at the morning from Babu Ghat (Kolkata-700001) and Howrah Station area. About 100µl of water was spread onto 1.5% Luria Bartoni-agar plate containing different concentration of antibiotics at 2-50µg/ml. MDR bacteria were selected in agar-plate containing ampicillin, streptomycin, chloramphenicol, tetracycline or ciprofloxacin at 50, 50, 34, 20 µg/ml respectively. As imipenem and meropenem resistant bacteria were present low (0.08-0.2 cfu/ml water), a modified method was followed. 2 ml 5x LB media was added into 10 ml River/Sea water at 2-10µg/ml concentration and was incubated 24 hrs to get drug resistant bacteria population (Chakraborty, 2015) . Meropenem resistant bacteria further selected on ampicillin, tetracycline, chloramphenicol and streptomycin to get the superbugs.
Antibiotics were purchased from HiMedia and stored at 2-50mg/ml at -20 O C. Antibiotic papers were also purchased from HiMedia according to CLSI standard. Antibiotic papers are:
AT-50 (aztreonam), COT-25µg (Cotrimoxazole), Met-10µg (methicillin), CAZ-30µg
TGC-15µg (tigecycline), LZ-10µg (linezolid), and IMP-10µg (imipenem).
The plasmid DNA was isolated from overnight culture using Alkaline-Lysis Method (Sambrook et al., 1982; Chakraborty & Hodgson, 1988) . 16S rDNA gene colour Sanger's dideoxy sequencing was performed by SciGenom Limited, Kerala, India (Ausubel et al., 1989) .
PCR amplification was performed using 1 unit Taq 1X TAE buffer at 50V for 2-4 hrs and visualized under UV light and photograph was taken (Chakraborty et al., 1993) . The 16S rRNA gene amplification and mdr genes sequencing are performed by conventional methods (Sanger et al., 1977; Chakraborty et al., 1991) . NCBI BLAST analysis was performed for bacterial specific gene analysis (www.ncbi.nlm.nih.gov/blast) and data was submitted to GenBank. NCBI databases were retrieved using the BLAST programmes (www.ncbi.nlm.nih.gov/blast) (Johnson et al., 2008) .
The complete genes are sequenced in plasmids and were analyzed by Seq-2 programme of BLAST. Multalin protein sequence software was used to get the nature of conserved sequences among metallo-class B β-lactamases (King and Strynadka, 2013 
Folic acid biosynthetic genes in MDR-plasmids
We also found folate and thimine metabolism enzymes in Sinorhizobium meliloti mega plasmid, pSymA (accession no. AE006469; 1354kb) like 5,10 methylene tetrahydrofolate reductase (protein id. AAK65825; nt. 1211022-1211975), formoyl tetrahydrofolate deformylase (protein id. AAK65824) and thiamine pyrophosphate binding enzyme (protein id. AAK65851) but no classical mdr gene but penicillin binding proteins (protein ids.
AAK65894, AAK65893) and many ABC or MFS transporters. This supports our hypothesis that bacteria will acquire more enzymes in the vitamin biosynthetic pathway to avert the action of antibiotics and will preserve the symbiotic relation in the intestine. So how and why such genes are now accumulating in MDR-plasmids is a important observation but needs research to elucidate if our hypothesis that all vitamin synthesizing enzymes will be in MDRplasmids to avert antibiotic actions on gut microbiota which are protected by symbiotic phenomenon during evolution (Wang et al., 2017) .
Biotin biosynthetic genes in MDR and Non-MDR plasmids
An acetyl-COA carboxylase biotin carboxy carrier protein subunit (protein id. ASK71473; Accession no. CP022359, nt. 109480-110718C) located in Shewanella bicestrii plasmids.
Rhizobium leguminosarum large plasmids (accession no. CP025013/ CP016287) have similar biotin carboxylase and biotin sulfoxide reductase (776aa; protein id. AUW45720) genes and also cobW genes involved in cobalamine biosynthesis. Ensifer adhaerens large plasmid pOV14b (1614kb) has 200 diversified ABC transporters and 60 diversified transcriptional regulators and few mdr genes (blaOXA-like ; protein id. AHK47346), PBP1A (protein id.
AHK47149) as well as acrB (protein id. AHK47037) and ermA/QacA (protein id.
AHK47565) drug efflux proteins, Search indicated that the plasmid had biotin synthesizing enzymes (bioB, bioD and bioF) at the nt. 983383-981237 (protein ids. AHK47270, AHK4768
and AHK47269 respectively). Thus multiple vitamin synthesizing genes are accumulating in mdr plasmids due to repeated use of complex antibiotics.
Riboflavin biosynthetic genes in large MDR plasmids
FAD synthase (phospho hydrolase type) was located in p2964TF plasmid of K. pneumoniae (accession no. KT935446; nt. 3669-2554). FAD-binding monooxygenase enzyme was reported in Ensifer plasmid pOV14b (protein id. AHK47466, nt. 1352625-1351060) as well as a FAD-dependent oxidoreductase (protein id. AHK47620).
Pyrodoxine biosynthetic gene in MDR-plsmids
A pyridoxine 5'-P oxidase (protein id. AHK47166) was reported in pOV14b large plasmid (accession no. CP007239) of Ensifer sp. and related to Sinorhizobium enzyme (65% similarity, protein id. WP_058323781).
Pantothenate biosynthetic gene in large MDR Plasmids
Enterobacter cloacae plasmid, p22ES-469 (Accession no. CM008897) has acquired enzymes involved in pantothenate metabolism (protein ids. PIA01523, PIA01562) and also in association with thi genes and many mdr genes. 
Niacin biosynthetic genes in MDR-plasmids
Many biosynthetic genes in large MDR plasmids
As discussed earlier, we detected many large plasmids have multiple vit genes. Enterobacter cloacae large plasmid p22ES-469 has many thi and pan genes (Miranda-Ríos et al., 1997) .
Shewanella bicestrii plasmid pSHE-CTX-M has cob and rib genes. Rhizobium leguminosarum very large plasmid also have multiple thi genes as well as bio and cob genes (accession no. CP025013). This implies that gradual selection of vit genes into plasmids have initiated and maintained during antibiotic exposure. Symbiotic bacteria contribute to the functional biodiversity in the aquatic world and influence the fitness of the host organisms and microhabitats ecosystem. It has been suggested that LPS, vitamins and butyrate from intestinal bacteria activate luminal cells to secrete interleukins and cytokines that help to synthesis diversified mdr genes in conjugative plasmids and chromosome to protect gut microbiota against action of high dose of antibiotics (Gibson et al., 2016 AFL55645, 809aa) and also in pBMB293 plasmid. We need to reduce global toxicity in water and our industries must know the knowledge of contamination of chemicals and heavy metals in water increasing superbugs spread.
Discussion
Conclusion
WHO has suggested to follow AMR Action Plan and G-20 leaders and Scientists have agreed to reduce antibiotics use in human, animal, and agricultural land as well as to augment research on novel therapeutics alternate to antibiotics (Villa et al., 2015) . We have purified organic phyto-extracts (Cassia fistula, Suregada multiflora, Syzygium aromaticum, Cinnamomum zeynalicum, etc) that inhibit Kolkata superbugs and gives a hope for new drug development (Chakraborty, 2015) . We slogan, "Come Back to Nature: Save Plants and Use as Medicine". Many technologies like enzybiotics, phage therapy and gene medicines are under development other than herbal therapy (Kutter et al., 2015) . Sadly, household water, sea water, rain water and river water are contaminated greatly with superbugs increasing deadly infections where MRSA Staphylococcus aureus, MDR Acinetobacter baumannii and NDM1 Escherichia coli infections are all antibiotic resistant. Thus we lost our win position using ampicillin, streptomycin, tetracycline, ciprofloxacin, azithromycin, and cefotaxime and imipenem drugs against MDR bacterial infections. The GenBank data analysis has proved our hypothesis that vitamin crisis in human due to antibiotic therapy. We think much analysis of unknown genes in superbug plasmids are necessary and likely NIH (NCBI, USA)
should act quickly. Perhaps DNA recombination enzymes like tranposases, resolvases, integrases, topoisomerases and plasmids partition enzymes are good target for development of therapeutics against superbugs. Trully, all famous drug companies are in horror to invest in new antibiotic discovery. But phage therapy (bacteriophages T4/θ/ϕ), enzybiotics (lysin, lysozyme), gene medicines (ribozyme, CASPER-CAS, IL gene therapy) and delivery of toxic drugs efficiently using nano-carriers (fullerenes, DNA-Origami) are frontier medical sciences to regulate the 21 st Century drug industry (Dunbar et al., 2018) . This work may also through some highlight into combat measure and novel drug design against superbugs and there is no similar report in the Pubmed database (Xu et al., 2014) .
